Pricing needs to balance the 'full scope' of responsibility, and reality

July 1, 2020 Comment

This is a preview of subscriber content

Subscribe now to continue reading.

Pharmaceutical companies are not charities. They use shareholder funds to invest in R&D with the goal of developing what need to be commercially viable products. This is a basic principle that some seem not to understand, or conveniently choose not to understand. …

Subscribe now to continue reading.

Latest Video

New Zealand accelerates medicines reform with major regulatory changes
November 12, 2025 - Latest News
Government adds new first-line treatment to the PBS for deadly blood cancer
November 13, 2025
Sanofi building an AI-literate organisation through expectations, over experiments
November 14, 2025 - Latest News
Every Government agency to appoint a 'Chief AI Officer' under national plan
November 12, 2025 - Latest News
FDA moves to lift long-standing hormone therapy warnings in major shift for women’s health
November 12, 2025 - Latest News

Pricing needs to balance the 'full scope' of responsibility, and reality

This is a preview of subscriber content

Latest Video

Most Read

New Zealand accelerates medicines reform with major regulatory changes

Government adds new first-line treatment to the PBS for deadly blood cancer

Sanofi building an AI-literate organisation through expectations, over experiments

Every Government agency to appoint a 'Chief AI Officer' under national plan

FDA moves to lift long-standing hormone therapy warnings in major shift for women’s health

New Stories

Biotron reports promising advances in Hepatitis B program as lead candidate shows strong antiviral activity

Recce Pharmaceuticals pays tribute to founder and scientific pioneer Dr Graham Melrose

PYC reports sustained vision gains in RP11 clinical trial

Sanofi building an AI-literate organisation through expectations, over experiments

Prospection says data access and leadership are critical to unlock AI’s potential in healthcare

The four 'H' words that can help drive the adoption of AI in health

Arrotex launches new PBS-listed combination therapy as gap emerges in hypertension treatments

Sign In

Pricing needs to balance the 'full scope' of responsibility, and reality

This is a preview of subscriber content

Latest Video

Most Read

New Zealand accelerates medicines reform with major regulatory changes

Government adds new first-line treatment to the PBS for deadly blood cancer

Sanofi building an AI-literate organisation through expectations, over experiments

Every Government agency to appoint a 'Chief AI Officer' under national plan

FDA moves to lift long-standing hormone therapy warnings in major shift for women’s health

Follow Us

New Stories

Biotron reports promising advances in Hepatitis B program as lead candidate shows strong antiviral activity

Recce Pharmaceuticals pays tribute to founder and scientific pioneer Dr Graham Melrose

PYC reports sustained vision gains in RP11 clinical trial

Sanofi building an AI-literate organisation through expectations, over experiments

Prospection says data access and leadership are critical to unlock AI’s potential in healthcare

The four 'H' words that can help drive the adoption of AI in health

Arrotex launches new PBS-listed combination therapy as gap emerges in hypertension treatments